JP4024673B2 - 保存安定性を有するイオントフォレシス用リザーバ電極及び該リザーバ電極を具えるイオントフォレシスシステム - Google Patents
保存安定性を有するイオントフォレシス用リザーバ電極及び該リザーバ電極を具えるイオントフォレシスシステム Download PDFInfo
- Publication number
- JP4024673B2 JP4024673B2 JP2002506803A JP2002506803A JP4024673B2 JP 4024673 B2 JP4024673 B2 JP 4024673B2 JP 2002506803 A JP2002506803 A JP 2002506803A JP 2002506803 A JP2002506803 A JP 2002506803A JP 4024673 B2 JP4024673 B2 JP 4024673B2
- Authority
- JP
- Japan
- Prior art keywords
- electrode
- reservoir
- patient
- polymeric material
- polymer material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000463 material Substances 0.000 claims abstract description 51
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 229910001514 alkali metal chloride Inorganic materials 0.000 claims abstract description 9
- 239000000853 adhesive Substances 0.000 claims abstract description 7
- 230000001070 adhesive effect Effects 0.000 claims abstract description 7
- 150000003841 chloride salts Chemical class 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 49
- 229940079593 drug Drugs 0.000 claims description 48
- 239000002861 polymer material Substances 0.000 claims description 35
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 30
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 29
- 238000004132 cross linking Methods 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 15
- 230000002745 absorbent Effects 0.000 claims description 15
- 239000002250 absorbent Substances 0.000 claims description 15
- 239000011780 sodium chloride Substances 0.000 claims description 15
- 239000004332 silver Substances 0.000 claims description 13
- -1 salt ions Chemical class 0.000 claims description 12
- 229910052709 silver Inorganic materials 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 10
- 238000012377 drug delivery Methods 0.000 claims description 10
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 9
- YLXIPWWIOISBDD-NDAAPVSOSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;4-[(1r)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CNC[C@H](O)C1=CC=C(O)C(O)=C1 YLXIPWWIOISBDD-NDAAPVSOSA-N 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
- 125000005907 alkyl ester group Chemical group 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 5
- 229960004393 lidocaine hydrochloride Drugs 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- 239000012458 free base Substances 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- 229960004106 citric acid Drugs 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 2
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 5
- 229910001507 metal halide Inorganic materials 0.000 claims 5
- 150000005309 metal halides Chemical class 0.000 claims 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 239000002585 base Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910001508 alkali metal halide Inorganic materials 0.000 claims 1
- 150000008045 alkali metal halides Chemical class 0.000 claims 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 230000001464 adherent effect Effects 0.000 abstract 2
- 238000003860 storage Methods 0.000 description 21
- 230000007797 corrosion Effects 0.000 description 17
- 238000005260 corrosion Methods 0.000 description 17
- 239000000017 hydrogel Substances 0.000 description 17
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 9
- 229910052783 alkali metal Inorganic materials 0.000 description 9
- 230000005865 ionizing radiation Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 238000010894 electron beam technology Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 4
- 229930182837 (R)-adrenaline Natural products 0.000 description 4
- HYKGUEIYMKVUSR-NPULLEENSA-N 2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide;4-[(1r)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C HYKGUEIYMKVUSR-NPULLEENSA-N 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 229960005139 epinephrine Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007772 electrode material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 239000012779 reinforcing material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical class OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000010416 ion conductor Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000003351 stiffener Substances 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/0436—Material of the electrode
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Electrotherapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/610,563 US6629968B1 (en) | 2000-06-30 | 2000-06-30 | Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode |
| PCT/US2001/020886 WO2002002182A2 (en) | 2000-06-30 | 2001-06-29 | Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004501727A JP2004501727A (ja) | 2004-01-22 |
| JP2004501727A5 JP2004501727A5 (enExample) | 2005-06-09 |
| JP4024673B2 true JP4024673B2 (ja) | 2007-12-19 |
Family
ID=24445534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002506803A Expired - Fee Related JP4024673B2 (ja) | 2000-06-30 | 2001-06-29 | 保存安定性を有するイオントフォレシス用リザーバ電極及び該リザーバ電極を具えるイオントフォレシスシステム |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6629968B1 (enExample) |
| EP (1) | EP1294439B1 (enExample) |
| JP (1) | JP4024673B2 (enExample) |
| AT (1) | ATE369891T1 (enExample) |
| AU (1) | AU2001273104A1 (enExample) |
| CA (1) | CA2413624C (enExample) |
| DE (1) | DE60129965T2 (enExample) |
| WO (1) | WO2002002182A2 (enExample) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6757560B1 (en) * | 1999-04-09 | 2004-06-29 | Novosis Pharma Ag | Transdermal delivery system (TDS) with electrode network |
| JP4033382B2 (ja) * | 2002-04-08 | 2008-01-16 | 久光製薬株式会社 | インスリン投与装置 |
| US7776600B2 (en) | 2002-04-18 | 2010-08-17 | Carnegie Mellon University | Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
| WO2003088925A2 (en) | 2002-04-18 | 2003-10-30 | Carnegie Mellon University | Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
| JP4089875B2 (ja) * | 2002-06-12 | 2008-05-28 | 共同印刷株式会社 | 凹部を含む電極装置 |
| JP3493359B1 (ja) * | 2003-03-20 | 2004-02-03 | 宣美 辛島 | イオン泳動式治療装置 |
| US7917205B2 (en) * | 2003-03-20 | 2011-03-29 | Nobuyoshi Karashima | Iontophoresis-based medical device |
| EP1608433B1 (en) * | 2003-03-31 | 2009-03-11 | ALZA Corporation | Electrotransport device having a reservoir housing having a flexible conductive element |
| JPWO2005020967A1 (ja) * | 2003-08-29 | 2007-11-01 | 久光製薬株式会社 | 電気的薬物移送製剤 |
| US20100016929A1 (en) * | 2004-01-22 | 2010-01-21 | Arthur Prochazka | Method and system for controlled nerve ablation |
| EP1706178B1 (en) | 2004-01-22 | 2013-04-24 | Rehabtronics Inc. | System for routing electrical current to bodily tissues via implanted passive conductors |
| US20050234516A1 (en) * | 2004-02-16 | 2005-10-20 | Gueret Jean-Louis H | Treatment kit, composite structure, electric exciter, and cosmetic treatment method |
| FR2866240B1 (fr) * | 2004-02-16 | 2006-06-23 | Oreal | Kit de traitement comportant une structure composite a appliquer sur la peau et un excitateur electrique |
| US20050228335A1 (en) * | 2004-04-07 | 2005-10-13 | Reddy Vilambi N | Physical, structural, mechanical, electrical and electromechanical features for use in association with electrically assisted delivery devices and systems |
| US20050228336A1 (en) * | 2004-04-07 | 2005-10-13 | Preston Keusch | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability |
| WO2006015299A2 (en) * | 2004-07-30 | 2006-02-09 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
| JP4728631B2 (ja) * | 2004-11-30 | 2011-07-20 | Tti・エルビュー株式会社 | イオントフォレーシス装置 |
| US7590444B2 (en) * | 2004-12-09 | 2009-09-15 | Tti Ellebeau, Inc. | Iontophoresis device |
| JP4731931B2 (ja) * | 2005-02-03 | 2011-07-27 | Tti・エルビュー株式会社 | イオントフォレーシス装置 |
| JP4793806B2 (ja) * | 2005-03-22 | 2011-10-12 | Tti・エルビュー株式会社 | イオントフォレーシス装置 |
| US8386029B2 (en) | 2005-03-31 | 2013-02-26 | Encore Medical Asset Corporation | Apparatus for electrotherapy drug delivery with added impurities |
| US20070027426A1 (en) * | 2005-06-24 | 2007-02-01 | Transcutaneous Technologies Inc. | Iontophoresis device to deliver active agents to biological interfaces |
| US8386030B2 (en) | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
| US8295922B2 (en) | 2005-08-08 | 2012-10-23 | Tti Ellebeau, Inc. | Iontophoresis device |
| US20070088331A1 (en) * | 2005-08-18 | 2007-04-19 | Transcutaneous Technologies Inc. | Method and apparatus for managing active agent usage, and active agent injecting device |
| KR20080047600A (ko) | 2005-09-15 | 2008-05-29 | 티티아이 엘뷰 가부시키가이샤 | 로드형 이온토포레시스 장치 |
| US20070078372A1 (en) * | 2005-09-30 | 2007-04-05 | Vyteris, Inc. | Iontophoresis Drug Delivery Formulation Providing Acceptable Sensation and Dermal Anesthesia |
| US20070083147A1 (en) * | 2005-09-30 | 2007-04-12 | Transcutaneous Technologies Inc. | Iontophoresis apparatus and method to deliver antibiotics to biological interfaces |
| US7574256B2 (en) | 2005-09-30 | 2009-08-11 | Tti Ellebeau, Inc. | Iontophoretic device and method of delivery of active agents to biological interface |
| US20070093788A1 (en) * | 2005-09-30 | 2007-04-26 | Darrick Carter | Iontophoresis method and apparatus for systemic delivery of active agents |
| WO2007041158A1 (en) * | 2005-09-30 | 2007-04-12 | Vyteris, Inc. | Iontophoresis drug delivery device providing acceptable depth and duration of dermal anesthesia |
| EP1928543A2 (en) * | 2005-09-30 | 2008-06-11 | Vyteris, Inc. | Pulsatile delivery of gonadotropin-releasing hormone from a pre-loaded integrated electrotransport patch |
| US20070078434A1 (en) * | 2005-09-30 | 2007-04-05 | Vyteris, Inc. | Indications For Local Transport of Anaesthetic Agents By Electrotransport Devices |
| JP5116482B2 (ja) * | 2005-11-14 | 2013-01-09 | 帝國製薬株式会社 | イオントフォレーシス用製剤 |
| WO2007079193A2 (en) | 2005-12-30 | 2007-07-12 | Tti Ellebeau, Inc. | Iontophoretic systems, devices, and methods of delivery of active agents to biological interface |
| US8483820B2 (en) * | 2006-10-05 | 2013-07-09 | Bioness Inc. | System and method for percutaneous delivery of electrical stimulation to a target body tissue |
| WO2008067409A2 (en) * | 2006-11-28 | 2008-06-05 | Polyplus Battery Company | Protected lithium electrodes for electro-transport drug delivery |
| US8062783B2 (en) | 2006-12-01 | 2011-11-22 | Tti Ellebeau, Inc. | Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices |
| WO2008087803A1 (ja) * | 2007-01-16 | 2008-07-24 | Hokkaido University | 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤 |
| US7844345B2 (en) * | 2007-02-08 | 2010-11-30 | Neuropace, Inc. | Drug eluting lead systems |
| US7813811B2 (en) * | 2007-02-08 | 2010-10-12 | Neuropace, Inc. | Refillable reservoir lead systems |
| WO2008101171A2 (en) * | 2007-02-16 | 2008-08-21 | Thermage, Inc. | Temperature sensing apparatus and methods for treatment devices used to deliver high frequency energy to tissue |
| US8197844B2 (en) | 2007-06-08 | 2012-06-12 | Activatek, Inc. | Active electrode for transdermal medicament administration |
| WO2009006349A2 (en) * | 2007-06-29 | 2009-01-08 | Polyplus Battery Company | Electrotransport devices, methods and drug electrode assemblies |
| EP2178598A4 (en) * | 2007-08-17 | 2012-08-15 | Isis Biopolymer Llc | IONTOPHORETIC DRUG DISTRIBUTION SYSTEM |
| US8738137B2 (en) | 2007-08-23 | 2014-05-27 | Bioness Inc. | System for transmitting electrical current to a bodily tissue |
| CA2697381A1 (en) * | 2007-08-23 | 2009-02-26 | Bioness, Inc. | System for transmitting electrical current to a bodily tissue |
| US9757554B2 (en) | 2007-08-23 | 2017-09-12 | Bioness Inc. | System for transmitting electrical current to a bodily tissue |
| US20090069740A1 (en) * | 2007-09-07 | 2009-03-12 | Polyplus Battery Company | Protected donor electrodes for electro-transport drug delivery |
| US8862223B2 (en) | 2008-01-18 | 2014-10-14 | Activatek, Inc. | Active transdermal medicament patch and circuit board for same |
| EP2329255A4 (en) | 2008-08-27 | 2014-04-09 | Edwards Lifesciences Corp | analyte |
| ES2655714T3 (es) | 2009-02-26 | 2018-02-21 | The University Of North Carolina At Chapel Hill | Sistema intervencionista de administración de fármacos |
| SG175341A1 (en) * | 2009-05-08 | 2011-11-28 | Isis Biopolymer Inc | Iontophoretic device with improved counterelectrode |
| US20110092881A1 (en) * | 2009-05-08 | 2011-04-21 | Isis Biopolymer Inc. | Iontophoretic device with contact sensor |
| WO2011002776A1 (en) * | 2009-06-29 | 2011-01-06 | Nitric Biotherapeutics, Inc. | Pharmaceutical formulations for iontophoretic delivery of an immunomodulator |
| JP5463136B2 (ja) | 2009-12-22 | 2014-04-09 | 帝國製薬株式会社 | イオントフォレーシス療法に用いる電極装置 |
| USD678534S1 (en) | 2010-07-20 | 2013-03-19 | Iontera, Inc. | Iontophoretic device for application to the brow/forehead of a person |
| CN103269748B (zh) * | 2010-12-22 | 2016-02-17 | 帝国制药株式会社 | 用于电离子透入疗法治疗的电极垫 |
| US9610440B2 (en) * | 2013-06-10 | 2017-04-04 | Iontera, Inc | Systems, devices, and methods for transdermal delivery |
| GB2524777A (en) * | 2014-04-02 | 2015-10-07 | Microarray Ltd | Dressing comprising electrodes |
| CN104287714A (zh) * | 2014-11-10 | 2015-01-21 | 青岛柏恩鸿泰电子科技有限公司 | 一种银/氯化银粉末电极 |
| EP3268080A1 (en) * | 2015-03-09 | 2018-01-17 | Koninklijke Philips N.V. | Iontophoretic device, arrangement and method |
| CN108883261B (zh) * | 2016-01-05 | 2021-09-28 | 生物传感器硏究所 | 用于递送药物的离子电渗设备及其制造方法 |
| US12324792B2 (en) | 2020-12-28 | 2025-06-10 | Smith & Nephew, Inc. | Methods for making and using pharmaceutical compositions for iontophoresis |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4416274A (en) | 1981-02-23 | 1983-11-22 | Motion Control, Inc. | Ion mobility limiting iontophoretic bioelectrode |
| JPS5810066A (ja) * | 1981-07-10 | 1983-01-20 | 株式会社アドバンス | イオントフオレ−ゼ用プラスタ−構造体 |
| CA1262564A (en) * | 1983-09-01 | 1989-10-31 | Minoru Sasaki | Iontophoresis device |
| US5135477A (en) | 1984-10-29 | 1992-08-04 | Medtronic, Inc. | Iontophoretic drug delivery |
| US4752285B1 (en) | 1986-03-19 | 1995-08-22 | Univ Utah Res Found | Methods and apparatus for iontophoresis application of medicaments |
| US5496266A (en) * | 1990-04-30 | 1996-03-05 | Alza Corporation | Device and method of iontophoretic drug delivery |
| US4989607A (en) * | 1989-03-30 | 1991-02-05 | Preston Keusch | Highly conductive non-stringy adhesive hydrophilic gels and medical electrode assemblies manufactured therefrom |
| US5143071A (en) * | 1989-03-30 | 1992-09-01 | Nepera, Inc. | Non-stringy adhesive hydrophilic gels |
| US5328455A (en) * | 1989-07-21 | 1994-07-12 | Iomed, Inc. | Rehydratable product and method of preparation thereof |
| US5374241A (en) | 1989-07-21 | 1994-12-20 | Iomed, Inc. | Electrodes for iontophoresis |
| US5084008A (en) * | 1989-12-22 | 1992-01-28 | Medtronic, Inc. | Iontophoresis electrode |
| US5125894A (en) * | 1990-03-30 | 1992-06-30 | Alza Corporation | Method and apparatus for controlled environment electrotransport |
| US5362308A (en) * | 1990-09-25 | 1994-11-08 | Rutgers, The State University Of New Jersey | Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes |
| MX9101782A (es) | 1990-10-29 | 1992-06-05 | Alza Corp | Dispositivo de suministro iontoforetico y metodo para hidratar el mismo |
| US5158537A (en) | 1990-10-29 | 1992-10-27 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
| WO1992015365A1 (en) * | 1991-03-11 | 1992-09-17 | Alza Corporation | Iontophoretic delivery device and method of making same |
| US5405317A (en) * | 1991-05-03 | 1995-04-11 | Alza Corporation | Iontophoretic delivery device |
| US5464387A (en) * | 1991-07-24 | 1995-11-07 | Alza Corporation | Transdermal delivery device |
| US5203768A (en) * | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
| US5310404A (en) * | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
| JP2542792B2 (ja) | 1992-11-05 | 1996-10-09 | ベクトン・ディッキンソン・アンド・カンパニー | ユ―ザ作動型のイオン導入式装置 |
| US6377847B1 (en) | 1993-09-30 | 2002-04-23 | Vyteris, Inc. | Iontophoretic drug delivery device and reservoir and method of making same |
| AU2286995A (en) * | 1994-04-08 | 1995-10-30 | Alza Corporation | Electrotransport system with ion exchange competitive ion capture |
| JPH08155041A (ja) * | 1994-12-05 | 1996-06-18 | Advance Co Ltd | イオントフォレシス用新規高能率電極システム |
| US5837281A (en) * | 1995-03-17 | 1998-11-17 | Takeda Chemical Industries, Ltd. | Stabilized interface for iontophoresis |
| US5990179A (en) * | 1995-04-28 | 1999-11-23 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
| US5853383A (en) * | 1995-05-03 | 1998-12-29 | Alza Corporation | Preparation for formulations for electrotransport drug delivery |
| US5983130A (en) * | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
| CA2208336A1 (en) * | 1996-06-20 | 1997-12-20 | Hisamitsu Pharmaceuticals Co., Inc. | A device structure for iontophoresis |
| US6350259B1 (en) * | 1996-09-30 | 2002-02-26 | Vyteris, Inc. | Selected drug delivery profiles using competing ions |
| FR2755372B1 (fr) * | 1996-11-07 | 1998-12-24 | Elf Aquitaine | Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet |
| JP2001505197A (ja) | 1996-11-14 | 2001-04-17 | アルザ・コーポレーション | リドカイン及びエピネフリンの電気的補助投与のための製剤 |
| US6004577A (en) * | 1997-08-12 | 1999-12-21 | Murdock; Thomas O. | Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions |
| US5882677A (en) * | 1997-09-30 | 1999-03-16 | Becton Dickinson And Company | Iontophoretic patch with hydrogel reservoir |
| US6295469B1 (en) * | 1997-11-14 | 2001-09-25 | Alza Corporation | Formulation for electrically assisted delivery of lidocaine and epinephrine |
| US6496727B1 (en) | 2000-05-31 | 2002-12-17 | Becton, Dickinson And Company | Medicament-loaded transdermal reservoir and method for its formation |
-
2000
- 2000-06-30 US US09/610,563 patent/US6629968B1/en not_active Expired - Fee Related
-
2001
- 2001-06-29 EP EP01952340A patent/EP1294439B1/en not_active Expired - Lifetime
- 2001-06-29 AU AU2001273104A patent/AU2001273104A1/en not_active Abandoned
- 2001-06-29 JP JP2002506803A patent/JP4024673B2/ja not_active Expired - Fee Related
- 2001-06-29 CA CA002413624A patent/CA2413624C/en not_active Expired - Fee Related
- 2001-06-29 WO PCT/US2001/020886 patent/WO2002002182A2/en not_active Ceased
- 2001-06-29 US US09/897,698 patent/US6635045B2/en not_active Expired - Fee Related
- 2001-06-29 AT AT01952340T patent/ATE369891T1/de not_active IP Right Cessation
- 2001-06-29 DE DE60129965T patent/DE60129965T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1294439A2 (en) | 2003-03-26 |
| ATE369891T1 (de) | 2007-09-15 |
| DE60129965D1 (de) | 2007-09-27 |
| JP2004501727A (ja) | 2004-01-22 |
| CA2413624A1 (en) | 2002-01-10 |
| EP1294439B1 (en) | 2007-08-15 |
| US20020062102A1 (en) | 2002-05-23 |
| AU2001273104A1 (en) | 2002-01-14 |
| WO2002002182A2 (en) | 2002-01-10 |
| US6635045B2 (en) | 2003-10-21 |
| CA2413624C (en) | 2007-09-18 |
| WO2002002182A3 (en) | 2002-06-27 |
| US6629968B1 (en) | 2003-10-07 |
| DE60129965T2 (de) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4024673B2 (ja) | 保存安定性を有するイオントフォレシス用リザーバ電極及び該リザーバ電極を具えるイオントフォレシスシステム | |
| US5344394A (en) | Iontophoretic device incorporating an electrotransport adhesive | |
| JP3149950B2 (ja) | イオン導入による投与デバイスおよび該デバイスを水和させる方法 | |
| US6862473B2 (en) | Iontophoretic drug delivery device and reservoir and method of making same | |
| US6275728B1 (en) | Thin polymer film drug reservoirs | |
| JP4183909B2 (ja) | 電解経皮配布装置のための無水薬物貯蔵部 | |
| JP2004501727A5 (enExample) | ||
| EP0457849B1 (en) | Electrotransport adhesive | |
| KR100534512B1 (ko) | 전기적으로 보조되는 리도케인 및 에피네프린의 전달을 위한제제 | |
| US7043297B2 (en) | Iontophoretic drug delivery device and reservoir and method of making same | |
| CA2664998A1 (en) | Pulsatile delivery of gonadotropin-releasing hormone from a pre-loaded integrated electrotransport patch | |
| WO1995009031A1 (en) | Iontophoretic device, reservoir and method of making |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050621 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050719 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051017 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20051026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060119 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061121 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070131 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070207 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070521 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070911 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071003 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101012 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |